Rather & Kittrell’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$330K Buy
359
+61
+20% +$61.8K 0.05% 89
2025
Q4
$320K Buy
+298
New +$285K 0.05% 90
2025
Q3
Sell
-1,307
Closed -$1.02M 100
2025
Q2
$1.02M Sell
1,307
-8
-0.6% -$6.22K 0.2% 43
2025
Q1
$1.09M Buy
+1,315
New +$1.09M 0.24% 36
2022
Q1
Sell
-191
Closed -$52K 195
2021
Q4
$52K Buy
+191
New +$48.4K 0.05% 125

Other funds holding LLY

Rather & Kittrell's LLY Position: Q1 2026 in Review

Rather & Kittrell increased its Eli Lilly (LLY) stake by 20% in Q1 2026, buying an estimated $61.8K and bringing the position to 359 shares worth $330K. The position accounts for 0.05% of the portfolio, ranked #89.

Rather & Kittrell first reported a position in LLY in Q4 2021 and has held it in 5 quarters since. The position peaked at $1.09M in Q1 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Rather & Kittrell held 359 shares of Eli Lilly worth $330K as of Q1 2026.
  • Rather & Kittrell bought 61 Eli Lilly shares in Q1 2026, an estimated $61.8K.
  • Eli Lilly made up 0.05% of Rather & Kittrell's portfolio in Q1 2026, its #89 holding.
  • Rather & Kittrell first reported a position in Eli Lilly in Q4 2021 and has held it in 5 quarters since.
  • Rather & Kittrell's Eli Lilly position peaked at $1.09M in Q1 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Rather & Kittrell's 13F filing for Q1 2026, filed 12 May 2026.